Immune Thrombocytopenia
📧 Sign up to get email alerts when something new happens for Immune Thrombocytopenia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-09-24Clinical Trial Update: Sequential rhTPO and Eltrombopag Following Glucocorticoids for Severe Adult ITP [Phase 4]
Phase 4 clinical trial evaluating sequential treatment with recombinant human thrombopoietin (rhTPO) followed by eltrombopag after glucocort…
-
CLINICAL_TRIALS research · 2025-09-19Clinical Trial Update: Ultrasound to Detect Splenomegally in Patients With Isolated Thrombocytopenia
A clinical trial update describes research using ultrasound to detect splenomegaly in patients with isolated thrombocytopenia, including pri…
-
CLINICAL_TRIALS research · 2025-09-16Clinical Trial Update: An Exploratory Study of CD19/CD22/BCMA CAR-T Cells (BZE2204) in Subjects With Relapsed or Refractory Autoimmune Diseases [EARLY_Phase 1]
An early-phase exploratory study evaluating BZE2204 CAR-T cells targeting CD19/CD22/BCMA for relapsed or refractory autoimmune diseases, cur…
-
CLINICAL_TRIALS research · 2025-09-08Clinical Trial Update: Vitamin D Satus in Adults With Newly Diagnosed ITP
A clinical trial update indicates a study assessing Vitamin D status in adults with newly diagnosed immune thrombocytopenia (ITP) is not yet…
-
CLINICAL_TRIALS research · 2025-09-08Clinical Trial Update: The Efficacy and Safety of Combined Teriflunomide and High-dose Dexamethasone in Newly Diagnosed Primary Immune Thrombocytopenia (TEMPO-2) [Phase 2]
A Phase 2 clinical trial (TEMPO-2) is evaluating the combination of teriflunomide and high-dose dexamethasone for newly diagnosed primary im…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-08-21Clinical Trial Update: Exploring the Efficacy, Safety of a Modified Starting Dosage of Avatrombopag in Immune Throbocytopenia (ITP) - a Pilot Study [Phase 4]
A Phase 4 pilot study is evaluating a modified starting dosage of avatrombopag for immune thrombocytopenia, currently recruiting.
-
CLINICAL_TRIALS research · 2025-08-08Clinical Trial Update: Anti CD19/BCMA CAR Gene Therapy for Relapsed/Refractory Immune Thrombocytopenia [NA]
A clinical trial evaluating an anti-CD19/BCMA CAR T-cell therapy for relapsed/refractory immune thrombocytopenia is currently recruiting at …
-
CLINICAL_TRIALS research · 2025-08-07Clinical Trial Update: Inaticabtagene Autoleucel Injection in the Treatment of Refractory Systemic Lupus Erythematosus-related Immune Thrombocytopenia [Phase 1]
Phase 1 clinical trial evaluating inaticabtagene autoleucel for refractory systemic lupus erythematosus-related immune thrombocytopenia is c…
-
CLINICAL_TRIALS research · 2025-08-05Clinical Trial Update: A Clinical Study of NAD in the Treatment of Immune Thrombocytopenia [Phase 1, Phase 2]
Ongoing Phase 1/2 clinical trial in China evaluating nicotinamide adenine dinucleotide (NAD) for immune thrombocytopenia.
-
CLINICAL_TRIALS research · 2025-08-05Clinical Trial Update: Anti-CD38 Antibody Treating Children With Primary Immune Thrombocytopenia (ITP) [Phase 2]
A Phase 2 clinical trial evaluating an anti-CD38 antibody for treating children with primary immune thrombocytopenia is currently recruiting…
-
CLINICAL_TRIALS research · 2025-07-31Clinical Trial Update: Safety, Tolerability, and Efficacy of NVG-2089 in Participants With Immune Thrombocytopenia [Phase 2]
A Phase 2 clinical trial evaluating NVG-2089 for safety, tolerability, and efficacy in immune thrombocytopenia is currently recruiting.
-
CLINICAL_TRIALS research · 2025-07-24Clinical Trial Update: A Study on the Safety and Efficacy of TQB3473 Tablets in the Treatment of Persistent or Chronic Primary Immune Thrombocytopenia (ITP) in Adults [Phase 2]
Phase 2 clinical trial evaluating the safety and efficacy of TQB3473 tablets for persistent or chronic primary immune thrombocytopenia in ad…
-
CLINICAL_TRIALS research · 2025-07-18Clinical Trial Update: RN1201 Injection in the Treatment of Antibody-Mediated Diseases [Phase 1]
Phase 1 trial update for RN1201 Injection targeting antibody-mediated platelet disorders. The study includes refractory immune-mediated plat…
-
CLINICAL_TRIALS research · 2025-07-17Clinical Trial Update: Longitudinal Cohort Study on Immune Thrombocytopenia Complicated With Acute Ischemic Stroke
A planned longitudinal cohort study examining patients with immune thrombocytopenia complicated by acute ischemic stroke, currently NOT_YET_…
-
CLINICAL_TRIALS research · 2025-07-16Clinical Trial Update: Longitudinal Observational Study on Immune Thrombocytopenia
This longitudinal observational study at Peking University People's Hospital investigates Immune Thrombocytopenia and is not yet recruiting.
-
CLINICAL_TRIALS research · 2025-07-15Clinical Trial Update: The Combination of Upadacitinib and High-dose Dexamethasone as First-line Treatment in Adult Immune Thrombocytopenia [Phase 2]
Phase 2 clinical trial evaluating the combination of upadacitinib and high-dose dexamethasone as first-line treatment for adults with immune…
-
CLINICAL_TRIALS research · 2025-07-15Clinical Trial Update: ITP Registry and Accompanying Biospecimen Collection
Clinical trial update detailing an Immune thrombocytopenia registry and accompanying biospecimen collection led by Jena University Hospital.
-
CLINICAL_TRIALS research · 2025-07-14Clinical Trial Update: An Observational, Multicenter Study to Evaluate the Use and Effectiveness of Doptelet® in Patients With ITP
An observational, multicenter study evaluating how Doptelet (eltrombopag) is used and its effectiveness in patients with immune thrombocytop…
-
CLINICAL_TRIALS research · 2025-07-14Clinical Trial Update: Anti-CD38 Antibody Treating Elderly Patients With Primary Immune Thrombocytopenia (ITP) [Phase 2]
A Phase 2 clinical trial is evaluating an anti-CD38 antibody in elderly patients with immune thrombocytopenia. The study is currently recrui…
-
CLINICAL_TRIALS research · 2025-07-04Clinical Trial Update: An Open-label Study of Povetacicept in Participants With Autoimmune Cytopenias [Phase 1, Phase 2]
Open-label Phase 1/2 study evaluating povetacicept in autoimmune cytopenias. The study includes immune thrombocytopenia and idiopathic throm…
-
CLINICAL_TRIALS research · 2025-06-17Clinical Trial Update: Romiplostim Plus Dexamethasone vs Dexamethasone in Patients With Newly Diagnosed Primary Immune Thrombocytopenia [Phase 3]
Phase 3 clinical trial comparing romiplostim plus dexamethasone versus dexamethasone alone in newly diagnosed primary immune thrombocytopeni…
-
CLINICAL_TRIALS research · 2025-06-17Clinical Trial Update: "Cytotoxic T Lymphocyte-Associated Antigen-4 (CTLA-4) Gene Single-nucleotide Polymorphism in Primary Immune Thrombocytopenic Purpura in Children"
A clinical trial is investigating CTLA-4 gene single-nucleotide polymorphisms in children with primary immune thrombocytopenia. The trial st…
-
CLINICAL_TRIALS research · 2025-06-12Clinical Trial Update: A Dose-escalation Study Followed by a Dose Optimal Study to Evaluate the Safety and Efficacy of CID-103 in Adults With Chronic Immune Thrombocytopenia [Phase 1, Phase 2]
A Phase 1/2 dose-escalation and dose-optimization study to evaluate the safety and efficacy of CID-103 in adults with chronic immune thrombo…
-
CLINICAL_TRIALS research · 2025-05-20Clinical Trial Update: A Study of TQB3473 Tablets Compared to Placebo in the Treatment of Adult Primary Immune Thrombocytopenia [Phase 3]
A Phase 3 clinical trial evaluating TQB3473 tablets versus placebo in adults with Primary Immune Thrombocytopenia is currently recruiting.
-
CLINICAL_TRIALS research · 2025-05-16Clinical Trial Update: A Phase 1/2 Study of ESG206 in Patients With Primary Immune Thrombocytopenia [Phase 1, Phase 2]
A Phase 1/2 study of ESG206 in patients with primary immune thrombocytopenia is currently recruiting. The trial aims to evaluate safety and …